Injectable Formulation Development Gains Momentum as Biologics and Complex Molecules Drive Demand
The pharmaceutical industry is witnessing a surge in demand for Injectable Formulation Development, fueled by the rapid expansion of biologics, peptide therapies, and complex small molecules. As more drug candidates require parenteral administration for optimal efficacy, the need for robust, scalable, and compliant injectable formulations has never been greater.
2026-05-19
Small Molecule APIs Drive Next-Generation Pharmaceutical Innovation and Supply Chain Resilience
The global pharmaceutical industry is undergoing a profound shift, yet small molecule APIs remain the backbone of modern therapeutics. Despite the rise of biologics and advanced modalities,
2026-05-12
55th Organic Process R&D Conference (OPRD)
Date: 20-22 May 2026 Venue: The Westin Harbour Castle | Toronto, Canada
2026-04-30
TIDES USA 2026: Oligonucleotide and Peptide Therapeutics
Date: 11-14 May 2026 Venue: Hynes Convention Center, Boston, MA
2026-04-30
Date: 13-15 May 2026 Venue: National Exhibition and Convention Center(Shanghai)
2026-04-30
Topical Formulation Services Accelerate Innovation in Dermatology and Drug Delivery
The pharmaceutical sector is experiencing rapid growth in Topical Formulation Services, driven by increasing demand for targeted, non-invasive therapies. As dermatology pipelines expand and new delivery technologies emerge, Topical Formulation Services are becoming essential for translating complex molecules into safe, effective treatments for patients worldwide.
2026-04-30
2026-05-14
2026-04-23
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Business Collaboration
Innovative Drug CDMO Services
Tel: 86-576-85588039 / 86-576-85580090
E-mail: bd@jiuzhoupharma.com
Established Business Services（API）
Tel: 86-576-88881561
E-mail: bd@jiuzhoupharma.com
